Neurophysiological basis of rapid eye movement sleep behavior disorder: Informing future drug development

Nature and Science of Sleep

Volumn 8, Issue , 2016, Pages 107-120

  Jennum, Poul ^a   Christensen, Julie A E ^a   Zoetmulder, Marielle ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Brain stem; Hypocretin; Hypothalamus; Motor control

Indexed keywords

EID: 84979582232     PISSN: None     EISSN: 11791608     Source Type: Journal    
DOI: 10.2147/NSS.S99240     Document Type: Review

References (126)

1. Jouvet M. Paradoxical sleep-a study of its nature and mechanisms. Prog Brain Res. 1965;18:20-62.
2. Schenck CH, Bundlie SR, Ettinger MG, Mahowald MW. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep. 1986;9:293-308.
3. Schenck CH, Montplaisir JY, Frauscher B, et al. Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy-a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group. Sleep Med. 2013;14:795-806.
4. Sforza E, Zucconi M, Petronelli R, Lugaresi E, Cirignotta F. REM sleep behavioral disorders. Eur Neurol. 1988;28:295-300.
5. Brooks PL, Peever JH. Impaired GABA and glycine transmission triggers cardinal features of rapid eye movement sleep behavior disorder in mice. J Neurosci. 2011;31:7111-7121.
6. Mattarozzi K, Bellucci C, Campi C, et al. Clinical, behavioural and polysomnographic correlates of cataplexy in patients with narcolepsy/cataplexy. Sleep Med. 2008;9:425-433.
7. Knudsen S, Gammeltoft S, Jennum PJ. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency. Brain. 2010;133:568-579.
8. Schenck CH, Boeve BF, Mahowald MW. Delayed emergence of a parkinsonian disorder or dementia in 81% of older males initially diagnosed with idiopathic REM sleep behavior disorder (RBD): 16 year update on a previously reported series. Sleep Med. 2013;14(8):744-748.
9. Iranzo A, Fernández-Arcos A, Tolosa E, et al. Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients. PLoS One. 2014;9:e89741.
10. Postuma RB, Gagnon JF, Vendette M, Fantini ML, Massicotte-Marquez J, Montplaisir J. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology. 2009;72:1296-1300.
11. Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology. 1996;46:388-393.
12. Terzaghi M, Zucchella C, Rustioni V, Sinforiani E, Manni R. Cognitive performances and mild cognitive impairment in idiopathic rapid eye movement sleep behavior disorder: results of a longitudinal follow-up study. Sleep. 2013;36:1527-1532.
13. Sorensen GL, Mehlsen J, Jennum P. Reduced sympathetic activity in idiopathic rapid-eye-movement sleep behavior disorder and Parkinson's disease. Auton Neurosci. 2013;179:138-141.
14. Kashihara K, Imamura T, Shinya T. Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson's disease. Parkinsonism Relat Disord. 2010;16:252-255.
15. Miyamoto T, Miyamoto M, Suzuki K, Nishibayashi M, Iwanami M, Hirata K. 123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder. Sleep. 2008;31:717-723.
16. Unger MM, Möller JC, Mankel K, et al. Patients with idiopathic rapid-eye-movement sleep behavior disorder show normal gastric motility assessed by the 13C-octanoate breath test. Mov Disord. 2011;26:2559-2563.
17. Petit D, Gagnon JF, Fantini ML, Ferini-Strambi L, Montplaisir J. Sleep and quantitative EEG in neurodegenerative disorders. J Psychosom Res. 2004;56:487-496.
18. Postuma RB, Gagnon JF, Montplaisir J. Clinical prediction of Parkinson's disease: planning for the age of neuroprotection. J Neurol Neurosurg Psychiatry. 2010;81:1008-1013.
19. Ross GW, Abbott RD, Petrovitch H, Tanner CM, White LR. Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience. Parkinsonism Relat Disord. 2012;18(suppl 1): S199-S202.
20. Noyce AJ, Bestwick JP, Silveira-Moriyama L, et al. PREDiCT-PD: identifying risk of Parkinson's disease in the community: methods and baseline results. J Neurol Neurosurg Psychiatry. 2014;85:31-37.
21. Saper CB, Fuller PM, Pedersen NP, Lu J, Scammell TE. Sleep state switching. Neuron. 2010;68:1023-1042.
22. Iber C. The American Academy Sleep Medicine Manual for the Scoring of Sleep and Associated Events. Westchester, IL: American Academy of Sleep Medicine; 2007.
23. Luppi PH, Clement O, Fort P. Paradoxical (REM) sleep genesis by the brainstem is under hypothalamic control. Curr Opin Neurobiol. 2013;23(5):786-792.
24. Saper CB. The neurobiology of sleep. Continuum (Minneap Minn). 2013;19:19-31.
25. Sapin E, Lapray D, Bérod A, et al. Localization of the brainstem GABAergic neurons controlling paradoxical (REM) sleep. PLoS One. 2009;4:e4272.
26. Verret L, Leger L, Fort P, Luppi PH. Cholinergic and noncholinergic brainstem neurons expressing Fos after paradoxical (REM) sleep deprivation and recovery. Eur J Neurosci. 2005;21:2488-2504.
27. Lu J, Sherman D, Devor M, Saper CB. A putative flip-flop switch for control of REM sleep. Nature. 2006;441:589-594.
28. Sastre JP, Buda C, Kitahama K, Jouvet M. Importance of the ventrolateral region of the periaqueductal gray and adjacent tegmentum in the control of paradoxical sleep as studied by muscimol microinjections in the cat. Neuroscience. 1996;74:415-426.
29. Crochet S, Onoe H, Sakai K. A potent non-monoaminergic paradoxical sleep inhibitory system: a reverse microdialysis and single-unit recording study. Eur J Neurosci. 2006;24:1404-1412.
30. Verret L, Fort P, Gervasoni D, Léger L, Luppi PH. Localization of the neurons active during paradoxical (REM) sleep and projecting to the locus coeruleus noradrenergic neurons in the rat. J Comp Neurol. 2006;495:573-586.
31. Boissard R, Gervasoni D, Schmidt MH, Barbagli B, Fort P, Luppi PH. The rat ponto-medullary network responsible for paradoxical sleep onset and maintenance: a combined microinjection and functional neuroanatomical study. Eur J Neurosci. 2002;16:1959-1973.
32. Clement O, Sapin E, Berod A, Fort P, Luppi PH. Evidence that neurons of the sublaterodorsal tegmental nucleus triggering paradoxical (REM) sleep are glutamatergic. Sleep. 2011;34:419-423.
33. Siegel JM. The neurobiology of sleep. Semin Neurol. 2009;29: 277-296.
34. Lai YY, Siegel JM. Pontomedullary glutamate receptors mediating locomotion and muscle tone suppression. J Neurosci. 1991;11: 2931-2937.
35. Mileykovskiy BY, Kiyashchenko LI, Kodama T, Lai YY, Siegel JM. Activation of pontine and medullary motor inhibitory regions reduces discharge in neurons located in the locus coeruleus and the anatomical equivalent of the midbrain locomotor region. J Neurosci. 2000;20:8551-8558.
36. Luppi PH, Gervasoni D, Boissard R, et al. Brainstem structures responsible for paradoxical sleep onset and maintenance. Arch Ital Biol. 2004;142:397-411.
37. Krenzer M, Anaclet C, Vetrivelan R, et al. Brainstem and spinal cord circuitry regulating REM sleep and muscle atonia. PLoS One. 2011;6:e24998.
38. Ramaligam V, Chen MC, Saper CB, Lu J. Perspectives on the rapid eye movement sleep switch in rapid eye movement sleep behavior disorder. Sleep Med. 2013;14:707-713.
39. Vetrivelan R, Fuller PM, Tong Q, Lu J. Medullary circuitry regulating rapid eye movement sleep and motor atonia. J Neurosci. 2009;29:9361-9369.
40. Webster HH, Friedman L, Jones BE. Modification of paradoxical sleep following transections of the reticular formation at the pontomedullary junction. Sleep. 1986;9:1-23.
41. Anaclet C, Pedersen NP, Fuller PM, Lu J. Brainstem circuitry regulating phasic activation of trigeminal motoneurons during REM sleep. PLoS One. 2010;5:e8788.
42. Lai YY, Hsieh KC, Nguyen D, Peever J, Siegel JM. Neurotoxic lesions at the ventral mesopontine junction change sleep time and muscle activity during sleep: an animal model of motor disorders in sleep. Neuroscience. 2008;154:431-443.
43. Vetrivelan R, Chang C, Lu J. Muscle tone regulation during REM sleep: neural circuitry and clinical significance. Arch Ital Biol. 2011;149:348-366.
44. Hassani OK, Henny P, Lee MG, Jones BE. GABAergic neurons intermingled with orexin and MCH neurons in the lateral hypothalamus discharge maximally during sleep. Eur J Neurosci. 2010;32: 448-457.
45. Mileykovskiy BY, Kiyashchenko LI, Siegel JM. Muscle tone facilitation and inhibition after orexin-a (hypocretin-1) microinjections into the medial medulla. J Neurophysiol. 2002;87:2480-2489.
46. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003 Mar-Apr;24(2):197-211.
47. Boeve BF, Silber MH, Ferman TJ, et al. Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med. 2013;14:754-762.
48. Boeve BF. REM sleep behavior disorder: updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann N Y Acad Sci. 2010;1184:15-54.
49. Boeve BF. Predicting the future in idiopathic rapid-eye movement sleep behaviour disorder. Lancet Neurol. 2010;9:1040-1042.
50. Lapierre O, Montplaisir J. Polysomnographic features of REM sleep behavior disorder: development of a scoring method. Neurology. 1992;42:1371-1374.
51. Frauscher B, Iranzo A, Gaig C, et al; SINBAR (Sleep Innsbruck Barcelona) Group. Normative EMG values during REM sleep for the diagnosis of REM sleep behavior disorder. Sleep. 2012;35:835-847.
52. Ferri R, Manconi M, Plazzi G, et al. A quantitative statistical analysis of the submentalis muscle EMG amplitude during sleep in normal controls and patients with REM sleep behavior disorder. J Sleep Res. 2008;17:89-100.
53. Montplaisir J, Gagnon JF, Fantini ML, et al. Polysomnographic diagnosis of idiopathic REM sleep behavior disorder. Mov Disord. 2010;25:2044-2051.
54. Frandsen R, Nikolic M, Zoetmulder M, Kempfner L, Jennum P. Analysis of automated quantification of motor activity in REM sleep behaviour disorder. J Sleep Res. 2015;24(5):583-590.
55. Kempfner J, Sorensen GL, Nikolic M, Frandsen R, Sorensen HB, Jennum P. Rapid eye movement sleep behavior disorder as an outlier detection problem. J Clin Neurophysiol. 2014;31:86-93.
56. Stefani A, Gabelia D, Högl B, et al. Long-term follow-up investigation of isolated rapid eye movement sleep without atonia without rapid eye movement sleep behavior disorder: a pilot study. J Clin Sleep Med. 2015;11(11):1273-1279.
57. Kang SH, Yoon IY, Lee SD, Han JW, Kim TH, Kim KW. REM sleep behavior disorder in the Korean elderly population: prevalence and clinical characteristics. Sleep. 2013;36:1147-1152.
58. Terzaghi M, Arnaldi D, Rizzetti MC, et al. Analysis of video-polysomnographic sleep findings in dementia with Lewy bodies. Mov Disord. 2013;28:1416-1423.
59. Hilker R, Burghaus L, Razai N, Jacobs AH, Szelies B, Heiss WD. Functional brain imaging in combined motor and sleep disorders. J Neurol Sci. 2006;248:223-226.
60. Happe S, Pirker W, Klosch G, Sauter C, Zeitlhofer J. Periodic leg movements in patients with Parkinson's disease are associated with reduced striatal dopamine transporter binding. J Neurol. 2003;250:83-86.
61. Sasai T, Inoue Y, Matsuura M. Clinical significance of periodic leg movements during sleep in rapid eye movement sleep behavior disorder. J Neurol. 2011;258:1971-1978.
62. Shouse MN, Siegel JM. Pontine regulation of REM sleep components in cats: integrity of the pedunculopontine tegmentum (PPT) is important for phasic events but unnecessary for atonia during REM sleep. Brain Res. 1992;571:50-63.
63. Kim YE, Yang HJ, Yun JY, Kim HJ, Lee JY, Jeon BS. REM sleep behavior disorder in Parkinson disease: association with abnormal ocular motor findings. Parkinsonism Relat Disord. 2014;20:444-446.
64. Christensen JA, Koch H, Frandsen R, et al. Classification of iRBD and Parkinson's disease patients based on eye movements during sleep. Conf Proc IEEE Eng Med Biol Soc. 2013;2013:441-444.
65. Fantini ML, Gagnon JF, Petit D, et al. Slowing of electroencephalogram in rapid eye movement sleep behavior disorder. Ann Neurol. 2003;53:774-780.
66. Massicotte-Marquez J, Carrier J, Décary A, et al. Slow-wave sleep and delta power in rapid eye movement sleep behavior disorder. Ann Neurol. 2005;57:277-282.
67. Hanyu H, Inoue Y, Sakurai H, et al. Regional cerebral blood flow changes in patients with idiopathic REM sleep behavior disorder. Eur J Neurol. 2011;18:784-788.
68. Iranzo A, Isetta V, Molinuevo JL, et al. Electroencephalographic slowing heralds mild cognitive impairment in idiopathic REM sleep behavior disorder. Sleep Med. 2010;11:534-539.
69. Sasai T, Matsuura M, Inoue Y. Electroencephalographic findings related with mild cognitive impairment in idiopathic rapid eye movement sleep behavior disorder. Sleep. 2013;36:1893-1899.
70. Bonanni L, Thomas A, Tiraboschi P, Perfetti B, Varanese S, Onofrj M. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up. Brain. 2008;131:690-705.
71. Morita A, Kamei S, Mizutani T. Relationship between slowing of the EEG and cognitive impairment in Parkinson disease. J Clin Neurophysiol. 2011;28:384-387.
72. Latreille V, Carrier J, Montplaisir J, Lafortune M, Gagnon JF. Non-rapid eye movement sleep characteristics in idiopathic REM sleep behavior disorder. J Neurol Sci. 2011;310:159-162.
73. Christensen JA, Kempfner J, Zoetmulder M, et al. Decreased sleep spindle density in patients with idiopathic REM sleep behavior disorder and patients with Parkinson's disease. Clin Neurophysiol. 2014;125:512-519.
74. Christensen JA, Nikolic M, Warby SC, et al. Sleep spindle alterations in patients with Parkinson's disease. Front Hum Neurosci. 2015;9: 233.
75. Latreille V, Carrier J, Lafortune M, et al. Sleep spindles in Parkinson's disease may predict the development of dementia. Neurobiol Aging. 2015;36:1083-1090.
76. Webster HH, Jones BE. Neurotoxic lesions of the dorsolateral pontomesencephalic tegmentum-cholinergic cell area in the cat. II Effects upon sleep-waking states. Brain Res. 1988;458:285-302.
77. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003;24:197-211.
78. Christensen JA, Jennum P, Koch H, et al. Sleep stability and transitions in patients with idiopathic REM sleep behavior disorder and patients with Parkinson's disease. Clin Neurophysiol. 2015;127(1):537-543.
79. Lanfranchi PA, Fradette L, Gagnon JF, Colombo R, Montplaisir J. Cardiac autonomic regulation during sleep in idiopathic REM sleep behavior disorder. Sleep. 2007;30:1019-1025.
80. Sorensen GL, Kempfner J, Zoetmulder M, Sorensen HB, Jennum P. Attenuated heart rate response in REM sleep behavior disorder and Parkinson's disease. Mov Disord. 2012;27:888-894.
81. Valappil RA, Black JE, Broderick MJ, et al. Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease. Mov Disord. 2010;25:2296-2303.
82. Miyamoto T, Miyamoto M, Inoue Y, Usui Y, Suzuki K, Hirata K. Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder. Neurology. 2006;67:2236-2238.
83. Miyamoto T, Miyamoto M, Iwanami M, Hirata K. Follow-up study of cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder. Eur J Neurol. 2011;18:1275-1278.
84. Oguri T, Tachibana N, Mitake S, Kawanishi T, Fukuyama H. Decrease in myocardial 123I-MIBG radioactivity in REM sleep behavior disorder: two patients with different clinical progression. Sleep Med. 2008;9:583-585.
85. Postuma RB, Lanfranchi PA, Blais H, Gagnon JF, Montplaisir JY. Cardiac autonomic dysfunction in idiopathic REM sleep behavior disorder. Mov Disord. 2010;25:2304-2310.
86. Basso MA, Evinger C. An explanation for reflex blink hyperexcitability in Parkinson's disease. II Nucleus raphe magnus. J Neurosci. 1996;16:7318-7330.
87. Valldeoriola F, Valls-Solé J, Tolosa E, Nobbe FA, Muñoz JE, Martí J. The acoustic startle response is normal in patients with multiple system atrophy. Mov Disord. 1997;12:697-700.
88. Kofler M, Müller J, Wenning GK, et al. The auditory startle reaction in parkinsonian disorders. Mov Disord. 2001;16:62-71.
89. Peter A, Hansen ML, Merkl A, Voigtländer S, Bajbouj M, Danker-Hopfe H. REM sleep behavior disorder and excessive startle reaction to visual stimuli in a patient with pontine lesions. Sleep Med. 2008;9: 697-700.
90. Zoetmulder M, Biernat HB, Nikolic M, Korbo L, Friberg L, Jennum PJ. Prepulse inhibition is associated with attention, processing speed, and 123I-FP-CIT SPECT in Parkinson's disease. J Parkinsons Dis. 2014;4:77-87.
91. Zoetmulder M, Biernat HB, Nikolic M, Korbo L, Jennum PJ. Sensorimotor gating deficits in multiple system atrophy: comparison with Parkinson's disease and idiopathic REM sleep behavior disorder. Parkinsonism Relat Disord. 2014;20:297-302.
92. Albin RL, Koeppe RA, Chervin RD, et al. Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology. 2000;55:1410-1412.
93. Iranzo A, Valldeoriola F, Lomeña F, et al. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol. 2011;10:797-805.
94. Miyamoto M, Miyamoto T. Neuroimaging of rapid eye movement sleep behavior disorder: transcranial ultrasound, single-photon emission computed tomography, and positron emission tomography scan data. Sleep Med. 2013;14:739-743.
95. Eisensehr I, Linke R, Noachtar S, Schwarz J, Gildehaus FJ, Tatsch K. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls. Brain. 2000;123(pt 6):1155-1160.
96. Iranzo A, Valldeoriola F, Lomeña F, et al. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol. 2011 Sep;10(9):797-805.
97. Nurmi E, Ruottinen HM, Bergman J, et al. Rate of progression in Parkinson's disease: a 6-[18F]fluoro-L-dopa PET study. Mov Disord. 2001;16:608-615.
98. Miyamoto T, Orimo S, Miyamoto M, et al. Follow-up PET studies in case of idiopathic REM sleep behavior disorder. Sleep Med. 2010;11:100-101.
99. Kim YK, Yoon IY, Kim JM, et al. The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder. Eur J Neurol. 2010;17:487-492.
100. García-Lorenzo D, Longo-Dos Santos C, Ewenczyk C, et al. The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease. Brain. 2013;136:2120-2129.
101. Ge J, Wu P, Peng S, et al. Assessing cerebral glucose metabolism in patients with idiopathic rapid eye movement sleep behavior disorder. J Cereb Blood Flow Metab. 2015;35(12):2062-2069.
102. Dauvilliers Y, Boudousq V, Lopez R, et al. Increased perfusion in supplementary motor area during a REM sleep behaviour episode. Sleep Med. 2011;12:531-532.
103. Mayer G, Bitterlich M, Kuwert T, Ritt P, Stefan H. Ictal SPECT in patients with rapid eye movement sleep behaviour disorder. Brain. 2015;138:1263-1270.
104. De Cock VC, Vidailhet M, Leu S, et al. Restoration of normal motor control in Parkinson's disease during REM sleep. Brain. 2007;130:450-456.
105. Stern MB. The preclinical detection of Parkinson's disease: ready for prime time? Ann Neurol. 2004;56:169-171.
106. Olsson B, Constantinescu R, Holmberg B, Andreasen N, Blennow K, Zetterberg H. The glial marker YKL-40 is decreased in synucleinopathies. Mov Disord. 2013;28:1882-1885.
107. Magdalinou NK, Paterson RW, Schott JM, et al. A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry. 2015;86:1240-1247.
108. Wennström M, Surova Y, Hall S, et al. The inflammatory marker YKL-40 is elevated in cerebrospinal fluid from patients with Alzheimer's but not Parkinson's disease or dementia with Lewy bodies. PLoS One. 2015;10:e0135458.
109. Anderson KN, Vincent A, Smith IE, Shneerson JM. Cerebrospinal fluid hypocretin levels are normal in idiopathic REM sleep behaviour disorder. Eur J Neurol. 2010;17:1105-1107.
110. Baumann CR, Dauvilliers Y, Mignot E, Bassetti CL. Normal CSF hypocretin-1 (orexin A) levels in dementia with Lewy bodies associated with excessive daytime sleepiness. Eur Neurol. 2004;52: 73-76.
111. Thannickal TC, Lai YY, Siegel JM. Hypocretin (orexin) cell loss in Parkinson's disease. Brain. 2007;130:1586-1595.
112. Fronczek R, Overeem S, Lee SY, et al. Hypocretin (orexin) loss in Parkinson's disease. Brain. 2007;130:1577-1585.
113. Aurora RN, Zak RS, Maganti RK, et al; Standards of Practice Committee; American Academy of Sleep Medicine. Best practice guide for the treatment of REM sleep behavior disorder (RBD). J Clin Sleep Med. 2010;6:85-95.
114. Kunz D, Mahlberg R. A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder. J Sleep Res. 2010;19:591-596.
115. Anderson KN, Shneerson JM. Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam. J Clin Sleep Med. 2009;5:235-239.
116. Shneerson JM. Successful treatment of REM sleep behavior disorder with sodium oxybate. Clin Neuropharmacol. 2009;32:158-159.
117. Onofrj M, Luciano AL, Thomas A, Iacono D, D'Andreamatteo G. Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism. Neurology. 2003;60:113-115.
118. Schapira AH, Olanow CW, Greenamyre JT, Bezard E. Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives. Lancet. 2014;384:545-555.
119. Henchcliffe C, Severt WL. Disease modification in Parkinson's disease. Drugs Aging. 2011;28:605-615.
120. Cruickshank TM, Reyes AR, Ziman MR. A systematic review and meta-analysis of strength training in individuals with multiple sclerosis or Parkinson disease. Medicine (Baltimore). 2015;94:e411.
121. Tomlinson CL, Herd CP, Clarke CE, et al. Physiotherapy for Parkinson's disease: a comparison of techniques. Cochrane Database Syst Rev. 2014;6:CD002815.
122. Shanahan J, Morris ME, Bhriain ON, Saunders J, Clifford AM. Dance for people with Parkinson disease: what is the evidence telling us? Arch Phys Med Rehabil. 2015;96:141-153.
123. Sixel-Doring F, Trautmann E, Mollenhauer B, Trenkwalder C. Rapid eye movement sleep behavioral events: a new marker for neurodegeneration in early Parkinson disease? Sleep. 2014;37:431-438.
124. Sixel-Doring F, Schweitzer M, Mollenhauer B, Trenkwalder C. Intraindividual variability of REM sleep behavior disorder in Parkinson's disease: a comparative assessment using a new REM sleep behavior disorder severity scale (RBDSS) for clinical routine. J Clin Sleep Med. 2011;7:75-80.
125. Mayer G, Kesper K, Ploch T, et al. Quantification of tonic and phasic muscle activity in REM sleep behavior disorder. J Clin Neurophysiol. 2008;25:48-55.
126. Jensen PS, Sorensen HB, Leonthin HL, Jennum P. Automatic sleep scoring in normals and in individuals with neurodegenerative disorders according to new international sleep scoring criteria. J Clin Neurophysiol. 2010;27:296-302.